Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-29
DOI
10.1007/s10875-019-00645-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe combined immunodeficiency in stimulator of interferon genes (STING) V154M/wild-type mice
- (2018) Delphine Bouis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
- (2018) Gina A. Montealegre Sanchez et al. JOURNAL OF CLINICAL INVESTIGATION
- Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling
- (2017) Isabelle Melki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Recurrent rhinovirus infections in a child with inherited MDA5 deficiency
- (2017) Ian T. Lamborn et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes
- (2017) Silvia Cerboni et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Detection of interferon alpha protein reveals differential levels and cellular sources in disease
- (2017) Mathieu P. Rodero et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Severe viral respiratory infections in children withIFIH1loss-of-function mutations
- (2017) Samira Asgari et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Familial chilblain lupus due to a gain-of-function mutation in STING
- (2016) Nadja König et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children
- (2016) Marie-Louise Frémond et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
- (2016) Gillian I. Rice et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy
- (2016) Justin Chia et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Type I interferonopathies in pediatric rheumatology
- (2016) Stefano Volpi et al. Pediatric Rheumatology
- Stimulator of Interferon Genes–Associated Vasculopathy With Onset in Infancy
- (2015) Justine Munoz et al. JAMA Dermatology
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- (2015) Ali Jabbari et al. EBioMedicine
- Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations
- (2014) Nadia Jeremiah et al. JOURNAL OF CLINICAL INVESTIGATION
- Activated STING in a Vascular and Pulmonary Syndrome
- (2014) Yin Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
- (2013) Gillian I Rice et al. LANCET NEUROLOGY
- Type I interferonopathies: a novel set of inborn errors of immunity
- (2011) Yanick J. Crow Annals of the New York Academy of Sciences
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now